US 9358204
Formulations of viloxazine
granted A61KA61K31/5375A61K9/00
Quick answer
US patent 9358204 (Formulations of viloxazine) held by Supernus Pharmaceuticals, Inc. expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/5375, A61K9/00, A61K9/146, A61K9/2054